P236 Superior lung function with once-daily QVA149 translates into improvements in patient-reported breathlessness compared with placebo and tiotropium in COPD patients: the BLAZE study
D'Urzo, A., Mahler, D., Decramer, M., Worth, H., White, T., Alagappan, V., Gallagher, N., Chen, H., Kulich, K., Banerji, D.Volume:
68
Language:
english
Journal:
Thorax
DOI:
10.1136/thoraxjnl-2013-204457.388
Date:
December, 2013
File:
PDF, 114 KB
english, 2013